INEST,Inc. Logo

INEST,Inc.

Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.

7111 | T

Overview

Corporate Details

ISIN(s):
JP3104810001
LEI:
Country:
Japan
Address:
豊島区東池袋一丁目25番9号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INEST, Inc. is a holding company that provides marketing and solution support services for both corporate enterprises and individual consumers. The company's corporate business segment focuses on developing, selling, operating, and maintaining application service provider (ASP) solutions, with a particular emphasis on chain stores and restaurants. It also offers consulting and on-site human resources support. The individual business segment is primarily engaged in the sale of mobile devices, including smartphones and tablets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:38
Registration Form
確認書
Japanese 9.0 KB
2025-11-14 07:35
Interim Report
半期報告書-第4期(2025/04/01-2026/03/31)
Japanese 229.9 KB
2025-06-30 07:22
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 27.2 KB
2025-06-27 06:03
M&A Activity
臨時報告書
Japanese 32.6 KB
2025-06-25 10:08
Governance Information
内部統制報告書-第3期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-25 10:06
Registration Form
確認書
Japanese 8.7 KB
2025-06-25 10:05
Annual Report
有価証券報告書-第3期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2025-06-24 10:14
Post-Annual General Meeting Information
臨時報告書
Japanese 28.3 KB
2025-01-16 07:37
M&A Activity
臨時報告書
Japanese 20.1 KB
2024-11-14 07:57
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-11-14 07:55
Interim Report
半期報告書-第3期(2024/04/01-2025/03/31)
Japanese 232.6 KB
2024-06-28 07:14
Governance Information
内部統制報告書-第2期(2023/04/01-2024/03/31)
Japanese 23.1 KB
2024-06-28 07:14
Registration Form
確認書
Japanese 8.8 KB
2024-06-28 07:13
Registration Form
有価証券報告書-第2期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-06-27 08:46
Post-Annual General Meeting Information
臨時報告書
Japanese 25.3 KB

Automate Your Workflow. Get a real-time feed of all INEST,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INEST,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INEST,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.